Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranes.

Authors

Aires, C?tia C P; Soveral, Gra?a; Lu?s, Paula B M; ten Brink, Herman J; de Almeida, Isabel Tavares; Duran, Marinus; Wanders, Ronald J A; Silva, Margarida F B

Publication Year 1905
Journal FEBS Letters
Chapter
Pages 3359-3366
Volume 582
Issue 23-24
Issn
Isbn
PMID 18775709.0
PMCID
DOI 10.1016/j.febslet.2008.08.028
URL http://dx.doi.org/10.1016/j.febslet.2008.08.028

The pyruvate uptake rate in inverted submitochondrial vesicles prepared from rat liver was optimized and further characterized; the potential inhibitory effects of the anticonvulsive drug valproic acid or 2-n-propyl-pentanoic acid (VPA), Delta4-valproic acid or 2-n-propyl-4-pentenoic acid and the respective coenzyme A (CoA) conjugates were studied in the presence of a proton gradient. All tested VPA metabolites inhibited the pyruvate uptake, but the CoA esters were stronger inhibitors (40% and 60% inhibition, respectively, for valproyl-CoA and Delta4-valproyl-CoA, at 1mM). At the same concentration, the specific inhibitor 2-cyano-4-hydroxycinnamate decreased the pyruvate uptake rate by 70%. The reported inhibition of the mitochondrial pyruvate uptake may explain the significant impairment of the pyruvate-driven oxidative phosphorylation induced by VPA.